Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
san francisco blog main
4
×
san francisco top stories
sickle cell disease
4
×
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alnylam pharmaceuticals
amgen
biogen
cancer
cancer immunotherapy
clinical trials
diagnostics
What
bio
roundup
acquisitions
ceo
drug
medicines
new
patients
advantages
aims
albert
announced
approach
bar
based
biggest
biotech
bourla
brings
called
collabs
company
covid
crispr
daniel
deal
debuts
developing
drugs
epigenetic
epigenetics
expect
field
flagship’s
future
gamble
gilead
gilead’s
help
imports
Language
unset
unknown
Current search:
biotech
×
" new york top stories "
×
" san francisco blog main "
×
" sickle cell disease "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More